share_log

微芯生物(688321.SH):西奥罗尼胶囊治疗胰腺癌临床试验申请获得受理

Microchip Biotech (688321.SH): Application for clinical trial of Theoroni capsules to treat pancreatic cancer accepted

Gelonghui Finance ·  Apr 9 04:27

Gelonghui, April 9 | Microchip Biotech (688321.SH) announced that the company and its wholly-owned subsidiary Chengdu Microchip Pharmaceutical Co., Ltd. recently received an “Notice of Acceptance” issued by the State Drug Administration for the registration of clinical trials of domestically produced drugs, and the clinical trial application for the treatment of pancreatic cancer with Theoroni capsules was accepted.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment